Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $702 | $578 | – | $818 |
| Short-Term Investments | $1 | $0 | – | $139 |
| Receivables | $512 | $513 | – | $444 |
| Inventory | $30 | $34 | – | $36 |
| Other Curr. Assets | $143 | $70 | – | $51 |
| Total Curr. Assets | $1,388 | $1,194 | – | $1,488 |
| Property Plant & Equip (Net) | $504 | $518 | – | $522 |
| Goodwill | $530 | $533 | – | $408 |
| Intangibles | $397 | $435 | – | $167 |
| Long-Term Investments | $80 | $89 | – | $98 |
| Tax Assets | $214 | $240 | – | $217 |
| Other NC Assets | $114 | $121 | – | $95 |
| Total NC Assets | $1,839 | $1,936 | – | $1,507 |
| Other Assets | $0 | $0 | – | $0 |
| Total Assets | $3,228 | $3,131 | – | $2,995 |
| Liabilities | – | – | – | – |
| Payables | $18 | $17 | – | $21 |
| Short-Term Debt | $10 | $12 | – | $14 |
| Tax Payable | $9 | $9 | – | $5 |
| Deferred Revenue | $31 | $32 | – | $32 |
| Other Curr. Liab. | $369 | $348 | – | $351 |
| Total Curr. Liab. | $438 | $418 | – | $422 |
| LT Debt | $28 | $35 | – | $37 |
| Deferred Rev, NC | $30 | $35 | – | $40 |
| Deferred Tax Liab, NC | $0 | $21 | – | $15 |
| Other NC Liab. | $100 | $136 | – | $108 |
| Total NC Liab. | $158 | $226 | – | $200 |
| Other Liabilities | $0 | $0 | – | $0 |
| Cap. Leases | $39 | $35 | – | $37 |
| Total Liabilities | $596 | $644 | – | $622 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | – | $0 |
| Common Stock | $0 | $0 | – | $0 |
| Retained Earnings | $2,635 | $2,496 | – | $2,392 |
| AOCI | -$13 | -$19 | – | -$37 |
| Other Equity | $0 | $0 | – | $0 |
| Total Equity | $2,623 | $2,477 | – | $2,355 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $9 | $10 | – | $17 |
| Total Liab. & Tot. Equity | $3,228 | $3,131 | – | $2,995 |
| Net Debt | -$663 | -$531 | $0 | -$767 |